DocDollars

Corcept Therapeutics

CA · United States · Reporting entity ID 100000000247

Total reported 2019–2025
$34.9M
#215 of 2,960 reporting companies — 0% of all reported industry payments
$16.9M in general payments across 154,341 records, plus $17.8M in research funding across 3,970 records.

How it breaks down

General payments $16,870,802
Research funding $17,830,304
Ownership & investment $234,410

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Corcept Therapeutics reported $34.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #215 of 2,960 reporting companies. 51% of that was research funding and 49% general payments such as consulting, speaking, food and travel. 154,341 general payment records and 3,970 research records were filed.

Common questions about Corcept Therapeutics

How much has Corcept Therapeutics paid US doctors?

Corcept Therapeutics reported $34,935,516 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $16,870,802 in general payments, $17,830,304 in research funding and $234,410 in ownership and investment interests.

How does Corcept Therapeutics rank among drug and device companies?

It ranks #215 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Corcept Therapeutics mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.